arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Transcode Therapeutics, Inc.

RNAZ

$4.00 ▼ -0.45 (-10.11%) at close

26 Visible periods

20 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Transcode Therapeutics, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $3.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -1120.8% ↘

FCF / Share $-5.43

Trailing P/E —

Price / Book 2.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-17.79M

↓ -47.2% —

FCF / Share Free cash flow per share

$-5.43

↑ +69.8% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -272.5% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -4303.96x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.56x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	69.7% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	91.7% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	96.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	99.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	88.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	99.8% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	99.7% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	99.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	99.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	91.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	81.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-22.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-478.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-65.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	72.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-27.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	-47.2% Weak ↑ Weak Improving Year-over-year change in net income	-127.2% Weak ↑ Weak Improving Year-over-year change in net income	-263.3% Weak ↓ Weak Declining Year-over-year change in net income	-263.3% Weak ↓ Weak Declining Year-over-year change in net income	-263.3% Weak ↓ Weak Declining Year-over-year change in net income	-44.7% Weak ↓ Weak Declining Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	20.4% Good ↑ Good Improving Year-over-year change in net income	-38.8% Weak ↑ Weak Improving Year-over-year change in net income	-38.8% Weak ↓ Weak Declining Year-over-year change in net income	-38.8% Weak ↓ Weak Declining Year-over-year change in net income	-83.4% Weak ↓ Weak Declining Year-over-year change in net income	22.6% Good ↑ Good Improving Year-over-year change in net income	22.6% Good ↑ Good Improving Year-over-year change in net income	22.6% Good ↑ Good Improving Year-over-year change in net income	-249.2% Weak ↑ Weak Improving Year-over-year change in net income	-10770.9% Weak Weak Year-over-year change in net income	-10770.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	69.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	97.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
FCF / Net Income (x)	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.39x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	3.17x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-1120.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-122.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-252.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	199.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-103.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-305.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-197.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-94.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-193.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1635.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-134.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.1% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	4.5% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	8.8% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-11.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-87.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-69.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-79.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-87.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-72.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-18.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-23.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-35.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	-130.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-967%)	—	-196.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1411%)	-117.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-883%)	293.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1854%)	-201.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1442%)	-251.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1777%)	-72.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-584%)	-249.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1761%)	-108.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-823%)	-230.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1635%)	—	-158.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1156%)	-42.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-27.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-20.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-19.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	89.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+494%)	57.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+281%)	23.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+57%)	1.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	3.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	-29623.95x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-27817.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-226.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3586.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-338.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-236.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-307.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-653.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-590.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-333.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-319.71x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6686.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-785.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-7086.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.04x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-12.84M	$-17.81M	$-2.84M	$-7.37M	$-11.57M	$-5.81M	—	—	—	$-2.77M	—	—	$-1.62M	$-4.97M	—	—	$-16.85M	$-20.83M	—	$-79.57K	—	$-828.02K	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-21.28	$-18.10	$-5.82	$-5.13	$-70.31	$-218.74	$-146.06	$-680.23	$-598.04	$-88.11K	$-45.23K	$-132.94K	$-246.50K	$-993.12K	$-246.87K	$-268.91K	$-201.68K	$-171.80K	$-149.39K	$448.18K	$-724.56K	$-134.45K	$-224.09K	$-22.41K	—	—
Free Cash Flow per Share (USD)	$-5.43	—	$-4.90	$-5.03	$-17.98	—	—	—	$-708.42	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.36	$11.27	$1.71	$7.37	$12.35	—	—	—	$824.04	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-151.36	$-141.45	$1.71	$7.37	$12.35	—	—	—	$824.04	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	916,968	—	833,683	833,654	172,192	—	15,893	7,631	5,563	—	117	33	19	—	17	17	17	—	15	6	6	—	6	6	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$11.37M	$18.49M	$1.78M	$6.68M	$10.53M	$4.32M	—	—	—	$964.85K	—	—	$-1.10M	$3.03M	—	—	$16.79M	$20.20M	—	$-992.88K	—	$426.35K	—	—	—	—
Total Equity (USD)	$1.25M	$10.34M	$1.43M	$6.15M	$10.29M	$-2.02M	$1.65M	$1.32M	$4.58M	$1.64M	$4.44M	$2.09M	$-236.79K	$3.24M	$8.24M	$12.43M	$17.00M	$20.40M	$23.16M	$-5.04M	$-7.85M	$-3.41M	$-2.62M	$-1.28M	$-1.15M	$-1.11M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$23.94K	$44.78K	$4.78K	$13.44K	$13.44K	$10.35K	$16.03K	$32.35K	$32.16K	$31.66K	$31.22K	$30.97K	$29.64K	$29.50K	$24.80K	$22.70K	$21.60K	$28.99K	$-28.99K	—	$1.25K	—	—	—	—	—
Net Income, GAAP (USD)	$-17.79M	$-13.44M	$-12.09M	$-12.09M	$-12.09M	$-5.92M	$-3.33M	$-3.33M	$-3.33M	$-4.09M	$-4.82M	$-4.82M	$-4.82M	$-5.13M	$-3.47M	$-3.47M	$-3.47M	$-2.80M	$-4.49M	$-4.49M	$-4.49M	$-801.53K	$-41.26K	$-41.26K	—	—
Operating Cash Flow (USD)	$-4.98M	$-8.14M	$-4.08M	$-4.19M	$-3.10M	$-3.15M	$-3.91M	$-2.34M	$-3.94M	$-5.66M	$-3.51M	$-4.39M	$-4.51M	$-4.02M	$-4.42M	$-3.37M	$-3.95M	$-1.60M	$-3.07M	—	$-522.15K	$-255.49K	$-130.84K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Transcode Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare RNAZ with peers